효소 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the enzymes market was valued at USD 14.23 billion in 2025 and is estimated to grow to USD 15.1 billion in 2026, with projections indicating it will reach USD 20.33 billion by 2031, registering a CAGR of 6.13% during 2026-2031.

This report is Segmented by Product Type (Industrial Enzymes and Specialty Enzymes), Source (Plant, Microbial, and Animal), Type (Carbohydrase's, Proteases, and More), Application (Food and Beverages, Pharmaceuticals and Biotechnology, and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Both Value (USD) and Volume (Tons).

Global Enzymes Market Trends and Insights

Rising health-conscious consumer behaviour

The increasing focus on health-conscious consumer behavior is driving growth in the enzymes market. Consumers are seeking products that promote better nutrition, wellness, and an improved quality of life. Greater awareness of healthier lifestyles has led to the adoption of enzyme-based solutions that enhance product functionality, improve nutritional value, and support natural processing methods. There is a growing preference for clean-label, naturally derived, and minimally processed products, which has boosted the demand for enzymes as effective biological alternatives to traditional processing methods. Enzymes contribute to improved digestibility, enhanced functional benefits, and the development of products that align with changing wellness trends. Furthermore, rising interest in preventive health, ingredient transparency, and sustainable production practices is motivating manufacturers to integrate enzyme technologies into their innovation strategies.

Growth of clean-label and natural ingredient trends

The growing preference for clean-label and natural ingredients is driven by consumer demand for products made with transparent, naturally derived, and sustainable solutions. Enzymes are increasingly adopted as they help manufacturers reduce reliance on synthetic additives and harsh chemical processes while maintaining product quality, functionality, and performance. The rising consumer focus on ingredient transparency, simpler formulations, and naturally processed products has promoted the use of enzyme-based technologies as effective biological alternatives. For example, according to the International Food Information Council (IFIC), in 2024, 36% of Americans identified "natural" or "organic" labels as important factors when choosing food, unde rscoring the increasing preference for naturally positioned products . This trend is encouraging manufacturers to adopt enzyme solutions that enable cleaner production methods, enhanced product characteristics, and sustainable processing practices.

Stringent and fragmented regulatory approval paths

The stringent and fragmented regulatory approval processes are limiting the growth of the enzymes market. Manufacturers must navigate complex safety assessments, adhere to quality standards, and meet region-specific approval requirements before commercialization. Differences in regulatory frameworks across various markets pose challenges in areas such as documentation, testing procedures, labeling standards, and approval timelines, complicating the global launch of enzyme-based products. Companies are required to provide evidence of enzyme safety, purity, production consistency, and potential impacts through extensive evaluations, resulting in longer development cycles and increased compliance efforts. Furthermore, evolving regulations related to biotechnology-derived enzymes, genetically modified production systems, and novel enzyme formulations create uncertainty for manufacturers and may delay product launches.

Other drivers and restraints analyzed in the detailed report include:

1. Technological advancements in enzyme engineering
2. Expansion of biofuel production and renewable energy initiatives
3. High cost of downstream purification and formulation

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The industrial enzymes segment accounted for 64.52% of the global enzymes market share in 2025, driven by the growing shift toward sustainable, efficient, and bio-based processing solutions. This growth is attributed to enzymes' ability to enhance process efficiency, improve product quality, reduce processing time, and decrease reliance on conventional chemical methods. The increasing preference for environmentally friendly production practices has further accelerated enzyme adoption, as they operate under mild conditions, reduce energy consumption, and minimize waste generation. Advancements in enzyme engineering, protein modification, and fermentation technologies have enhanced enzyme stability, specificity, and performance, enabling broader commercial applications. The rising demand for high-performance biological catalysts, improved manufacturing productivity, and customized enzyme solutions has fostered innovation and large-scale production in this segment.

The specialty enzymes segment is projected to be the fastest-growing product type, with a CAGR of 7.23% during 2026-2031. This growth is driven by increasing demand for highly specific and advanced enzyme solutions. Continuous advancements in enzyme modification, protein engineering, and biotechnology are improving enzyme efficiency, selectivity, and functional performance. The rising preference for precision-based biological solutions has accelerated the development of customized enzymes tailored for targeted processes and optimized outcomes. Innovations in recombinant technologies and enzyme optimization techniques are enabling the creation of enzymes with enhanced stability, extended activity duration, and improved compatibility across diverse operating conditions.

The microbial-sourced enzymes segment accounted for 61.23% of the global enzymes market share in 2025, driven by their high production efficiency, scalability, and consistent enzyme quality. The segment's growth is attributed to the advantages of microorganisms, such as faster growth cycles, ease of cultivation, and the ability to produce large quantities of enzymes through controlled processes. Advancements in microbial strain improvement, fermentation technologies, and genetic engineering have significantly enhanced enzyme yield, purity, stability, and functional performance, making microbial sources a preferred choice for commercial enzyme production. Their adaptability for modifications, including improved temperature tolerance, enhanced activity, and extended operational stability, has further increased their adoption across various applications. Additionally, the growing emphasis on sustainable production methods and the development of cost-effective enzyme manufacturing techniques have bolstered the reliability and efficiency of microbial enzyme production.

The animal-sourced enzymes segment is expected to grow at a CAGR of 6.58% during 2026-2031, fueled by the rising demand for naturally derived enzymes with high catalytic efficiency and specialized functional properties. The segment's growth is supported by the unique biochemical characteristics of animal-derived enzymes, such as strong specificity, reliability, and effectiveness in targeted processes. Advances in extraction, purification, and stabilization technologies have improved enzyme quality, consistency, and performance, facilitating broader commercial acceptance. Enhanced processing methods have also increased enzyme recovery efficiency while preserving biological activity and functional integrity. Furthermore, the focus on developing highly purified enzyme formulations and innovations aimed at improving stability, safety, and performance under diverse conditions is driving the segment's growth prospects.

Complete Report Scope:

• By Product Type
  • Industrial Enzymes
  • Specialty Enzymes
• By Source
  • Plant
  • Microbial
  • Animal
• By Type
  • Carbohydrases
  • Proteases
  • Lipases
  • Others
• By Application
  • Food and Beverages
  • Pharmaceuticals and Biotechnology
  • Diagnostics and Clinical Testing
  • Detergents and Household Care
  • Biofuels and Industrial Processing
  • Animal Feed
  • Textiles and Leather
  • Paper and Pulp
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Belgium
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Indonesia
    • South Korea
    • Thailand
    • Singapore
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

North America accounted for 31.87% of the global enzymes market share in 2025, supported by a well-established enzyme production and utilization ecosystem, advancements in biotechnology, and widespread adoption of enzyme-based solutions in industrial processes. The region's growth is driven by a mature industrial enzyme ecosystem, particularly in large-scale corn wet milling, soy processing, and ethanol production, which sustain the demand for efficient biological catalysts. According to the United States Department of Agriculture (USDA), total soy bean production for 2025/2026 is projected at 115.99 million metric tons, ensuring a steady supply of agricultural feedstocks for enzyme-driven processing activities . Additionally, increasing investments in enzyme engineering, fermentation technologies, and sustainable processing practices continue to reinforce North America's leadership in the global enzymes market.

Asia-Pacific is expected to be the fastest-growing region, with a projected CAGR of 7.06% during 2026-2031. This growth is fueled by the rapid expansion of biotechnology capabilities, increasing industrial adoption of enzyme-based processes, and rising demand for sustainable and efficient production technologies. Europe remains one of the largest regions in the enzymes market, supported by a strong regulatory emphasis on sustainability, advanced research infrastructure, and the development of innovative enzyme technologies. The region's commitment to bio-based solutions, circular production practices, and continuous improvements in enzyme performance underpins steady market expansion. Europe's focus on sustainability and innovation ensures its continued prominence in the global enzymes market.

South America and the Middle East and Africa are emerging regions in the global enzymes market, driven by increasing awareness of enzyme-based technologies, improving industrial capabilities, and growing adoption of sustainable processing methods. South America is experiencing growth due to the expansion of biological processing activities and the greater use of enzyme solutions to enhance productivity and efficiency. In the Middle East and Africa, the gradual adoption of advanced enzyme technologies is supported by the modernization of production processes and a growing interest in sustainable alternatives.

1. Novozymes A/S
2. International Flavors and Fragrances Inc.
3. DSM-Firmenich AG
4. BASF SE
5. Kerry Group plc
6. Associated British Foods plc
7. Amano Enzyme Inc.
8. Advanced Enzyme Technologies Ltd.
9. AB Enzymes GmbH
10. Codexis, Inc.
11. Biocatalysts Ltd.
12. Enzyme Development Corporation
13. Chr. Hansen Holding A/S
14. Merck KGaA
15. Thermo Fisher Scientific Inc.
16. Promega Corporation
17. Takara Bio Inc.
18. F. Hoffmann-La Roche Ltd.
19. Sanofi S.A.
20. Enzyme Solutions Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising health-conscious consumer behaviour
  • 4.2.2 Growth of clean-label and natural ingredient trends
  • 4.2.3 Technological advancements in enzyme engineering
  • 4.2.4 Expansion of biofuel production and renewable energy initiatives
  • 4.2.5 Expansion of precision fermentation capacity
  • 4.2.6 Shift toward low-energy, low-waste processing
• 4.3 Market Restraints
  • 4.3.1 Stringent and fragmented regulatory approval paths
  • 4.3.2 High cost of downstream purification and formulation
  • 4.3.3 Dependence on feedstock-grade fermentation inputs
  • 4.3.4 Availability of alternative chemical-based processing solutions
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)

• 5.1 By Product Type
  • 5.1.1 Industrial Enzymes
  • 5.1.2 Specialty Enzymes
• 5.2 By Source
  • 5.2.1 Plant
  • 5.2.2 Microbial
  • 5.2.3 Animal
• 5.3 By Type
  • 5.3.1 Carbohydrases
  • 5.3.2 Proteases
  • 5.3.3 Lipases
  • 5.3.4 Others
• 5.4 By Application
  • 5.4.1 Food and Beverages
  • 5.4.2 Pharmaceuticals and Biotechnology
  • 5.4.3 Diagnostics and Clinical Testing
  • 5.4.4 Detergents and Household Care
  • 5.4.5 Biofuels and Industrial Processing
  • 5.4.6 Animal Feed
  • 5.4.7 Textiles and Leather
  • 5.4.8 Paper and Pulp
  • 5.4.9 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.1.4 Rest of North America
  • 5.5.2 Europe
    • 5.5.2.1 United Kingdom
    • 5.5.2.2 Germany
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Netherlands
    • 5.5.2.7 Poland
    • 5.5.2.8 Belgium
    • 5.5.2.9 Sweden
    • 5.5.2.10 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 Indonesia
    • 5.5.3.6 South Korea
    • 5.5.3.7 Thailand
    • 5.5.3.8 Singapore
    • 5.5.3.9 Rest of Asia-Pacific
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Colombia
    • 5.5.4.4 Chile
    • 5.5.4.5 Peru
    • 5.5.4.6 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 South Africa
    • 5.5.5.2 Saudi Arabia
    • 5.5.5.3 United Arab Emirates
    • 5.5.5.4 Nigeria
    • 5.5.5.5 Egypt
    • 5.5.5.6 Morocco
    • 5.5.5.7 Turkey
    • 5.5.5.8 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Positioning Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 Novozymes A/S
  • 6.4.2 International Flavors and Fragrances Inc.
  • 6.4.3 DSM-Firmenich AG
  • 6.4.4 BASF SE
  • 6.4.5 Kerry Group plc
  • 6.4.6 Associated British Foods plc
  • 6.4.7 Amano Enzyme Inc.
  • 6.4.8 Advanced Enzyme Technologies Ltd.
  • 6.4.9 AB Enzymes GmbH
  • 6.4.10 Codexis, Inc.
  • 6.4.11 Biocatalysts Ltd.
  • 6.4.12 Enzyme Development Corporation
  • 6.4.13 Chr. Hansen Holding A/S
  • 6.4.14 Merck KGaA
  • 6.4.15 Thermo Fisher Scientific Inc.
  • 6.4.16 Promega Corporation
  • 6.4.17 Takara Bio Inc.
  • 6.4.18 F. Hoffmann-La Roche Ltd.
  • 6.4.19 Sanofi S.A.
  • 6.4.20 Enzyme Solutions Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK